Microbiosci, the division of Creative Biogene, the leading biotechnology solutions company with a unique blend of life sciences domain expertise and state-of-the-art technology capabilities that will complement and help accelerate the research in pharmaceutical and biotechnology industry, today announced that it has released microbial genome editing services which will backup the new ear in molecular biology research and further development. —
Microbiosci utilizes its extensive expertise in CRISPR/Cas9 genome editing technology to generate genetically modified mouse, rat, cancer, and stem cell lines, and to make multiple modifications to target genes. As a professional of CRISPR/Cas9 technology, Microbiosci has genetically engineered more than 1800 unique cell lines and animal models for disease modeling, functional genomics, target recognition, antibody verification, and drug discovery and screening verification, etc.
The rapid progress in developing Cas9 as a tool set for cell and molecular biology research is very remarkable, which may be due to the simplicity, efficiency and versatility of the system. The Microbial Genome Editing services offered by Microbiosci include CRISPR/Cas9-mediated genome editing services, the talented scientists have extensive experience in gene knockout, knock-in/replacement and site-directed mutagenesis.
CRISPR technology is derived from the immune system in bacteria and archaea. As an effective genome-scale editing tool. It has revolutionized traditional genetic engineering methods and promoted strain engineering as never before. So far, the CRISPR/Cas9 system has quickly become a transformative and powerful tool for editing genomes in many eukaryotes, but its application in bacteria is still ineffective and limited. Since many bacteria do not have a major repair pathway like eukaryotes, CRISPR-induced double-strand breaks (DSB) are lethal. In order to improve the recombination rate, it is used in combination with λ-Red recombination and CRISPR/Cas9 nuclease system to achieve a variety of highly accurate and traceless genome modifications. It is a powerful and effective tool for selecting microorganism production strains and obtaining new metabolites.
As a leader in microbial genome editing, Microbiosci provides a "one-stop service" suitable for genetic research needs. The in-house expertise in gene knockout, knock-in/replacement and site-directed mutagenesis can guarantee high quality services range from sgRNA vector construction to genome editing, clone selection and verification.
“Microbiosci is the premier institution providing professional and comprehensive genome editing services. With many years of experience, we can use CRISPR technology to meet the needs of your specific projects, thereby adding value to your research projects. We provide affordable, comprehensive customized services, and have a fast turnaround time to meet the requirements of your project.” said Marcia Brady, the marketing director of Creative Biogene, she also added, “Microbiosci is committed to providing complete solutions for genome editing to help you complete every step of the genome editing workflow. You can also combine it with our downstream customized laboratory services to achieve a seamless project workflow.”
Microbiosci, as the division of Creative Biogene, is always dedicated to satisfying the needs of clients covering more than 50 countries and districts. As a leading custom service provider in delivering medicine microbiology solutions, Microbiosci has become a well-recognized industry leader with years of experience and professional scientists.
Release ID: 88965586